The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
Market Samachar is a news aggregator. This article was originally published by Medical News Today. Tap the button above to read the full story on their site.